Cel . To investigate in both humans and in a defined murine system the effects of mixed exposure to subclinical concentrations of contact irritants. To determine the genetic control of susceptibility to irritants. To describe the role of cytokines, especially TNF-a, in induction of irritant contact dermatitis. To characterize the role of heat shock protein (hsp) 70 and the induction of oxidative stress in the induction and prevention of irritant contact dermatitis reactions. To design an in vitro test to characterize the capacity of irritant compounds to regulate cytokines in keratinocytes, a test that partially will eliminate the need for animal testing.Irritant contact dermatitis affects approximately 2% of the population of the European Union, and in some risk occupations affects up to 15% of workers. Despite its prevalence however little is known about its pathogenesis although pro-inflammatory mediators (cytokines), particularly TNF-a, are thought to play a critical role. Furthermore predictive tests of irritant potential are unreliable and are only capable of examine irritants individually, whereas in many occupations several irritants may exist. This is a matter of considerable importance since there is evidence that irritants may have additive or synergistic effects.Initially, we want to titre in vivo dose/effect relationship of known irritants on the induction of clinical reaction and on cytokine induction, especially TNF-a, and oxidative stress to demonstrate a possible additive effect of irritants following mixed exposures. We want to use these in vivo findings to establish an in vitro screening assay based on the capacity of irritative compounds to induce TNF-a in cultured keratinocytes that partially could eliminate the need for animal testing. Furthermore, we want to demonstrate whether differences in susceptibility towards irritant compounds is controlled at the genetic-level making it possible to identify individuals genetically at increased risk to develop irritant contact dermatitis. One of the major targets for such an involvement is the demonstration of TNF-a polymorphisms. We therefor investigate, both in humans and in defined mouse strains differing only at the TNF-a locus, the correlation between polymorphisms at the TNF-a locus and the capacity to develop irritant reactions following exposure. This could facilitate the identification of risk groups and allow information that aid prevention of this disabling condition of considerable socio-economic impact in Europe. Furthermore, we want to investigate whether cells can be made more resistant towards the harmful effects of irritant compounds by e.g. reducing the capacity of irritants to induce an oxidative stress in the cells and by over-expressing hsp and finally whether this affects the cell in its behavior to secrete inflammatory cytokines. Dziedzina nauki natural sciencesbiological sciencesbiochemistrybiomoleculesproteins Program(-y) FP4-BIOMED 2 - Specific research, technological development and demonstration programme in the field of biomedicine and health, 1994-1998 Temat(-y) 4.5.1 - Dose / effect relationships of agents Zaproszenie do składania wniosków Data not available System finansowania CSC - Cost-sharing contracts Koordynator Københavns Universitet Wkład UE Brak danych Adres 65,Niels Andersens Vej 2900 Køpenhavn Dania Zobacz na mapie Koszt całkowity Brak danych Uczestnicy (3) Sortuj alfabetycznie Sortuj według wkładu UE Rozwiń wszystko Zwiń wszystko Istituti Fisioterapici Ospitalieri Włochy Wkład UE Brak danych Adres Via San Gallicano 25/A 00153 Roma Zobacz na mapie Koszt całkowity Brak danych United Medical and Dental Schools of Guy's and St Thomas's Hospitals Zjednoczone Królestwo Wkład UE Brak danych Adres Lambeth Palace Road SE1 7EH London Zobacz na mapie Koszt całkowity Brak danych WESTFAELISCHE WILHELMS - UNIVERSITAET MUENSTER Niemcy Wkład UE Brak danych Adres 56,Von-Esmarschstrasse 56 48149 MUENSTER Zobacz na mapie Koszt całkowity Brak danych